Nicotinamide Adenine Dinucleotide
Also known as: NAD+, NAD, oxidized nicotinamide adenine dinucleotide, β-NAD+
2 notable studies · 2 references
TLDR
NAD+ is an essential endogenous coenzyme involved in cellular energy metabolism, DNA repair, sirtuin activity, and numerous signaling pathways, but the extensive evidence establishing NAD biology should not be confused with much more limited evidence that externally administered NAD+ produces anti-aging or other therapeutic benefits in humans.
Research Supports
- Studied for its fundamental role in cellular energy metabolism (redox reactions, mitochondrial function)
- Investigated for how NAD+ availability changes with aging and disease
- Studied as a substrate for sirtuins, PARPs, CD38, and SARM1 signaling
- Investigated in relation to DNA repair and oxidative-stress responses
- Human evidence concentrates on NAD+ precursors (NR, NMN) rather than administered NAD+ itself
Observations Reported in Research
- Age-associated NAD+ decline was linked to impaired nuclear-mitochondrial communication, reversible in aged mice (Gomes et al., 2013)
- Increased CD38 activity in aging tissue was shown to contribute to declining NAD+ and NMN levels in mice (Chini et al., 2020)
- Both notable mechanistic studies used animal/cellular models rather than direct administration of NAD+ to humans
These are brief summaries of what the referenced research examined or reported — not conclusions about safety or effectiveness, and not medical advice. See Notable Studies and Sources & References below for the full context and citations.
At a Glance
Classification: Endogenous nucleotide coenzyme; redox cofactor; metabolic signaling molecule
NAD+ is an essential molecule found in virtually every living cell. It is not a peptide. It is an endogenous dinucleotide coenzyme central to cellular energy metabolism. NAD+ participates in two broad categories of biology: 1. Redox metabolism NAD+ accepts electrons to become NADH during reactions involved in energy production. 2. NAD+-consuming signaling NAD+ serves as a substrate for enzymes including: • Sirtuins • PARPs • CD38 • SARM1 Research involving NAD+ has exploded because cellular NAD metabolism changes with aging and disease. That has generated interest in: • Aging • Mitochondrial function • Metabolic disease • DNA repair • Neurodegeneration • Exercise • Circadian biology • NAD+ precursors such as NR and NMN But an important distinction is routinely lost: Evidence that NAD+ metabolism matters ≠ evidence that externally administered NAD+ reverses aging or treats disease.
What Is Nicotinamide Adenine Dinucleotide?
NAD stands for Nicotinamide Adenine Dinucleotide. It exists primarily in two redox states: NAD+ → oxidized NADH → reduced During metabolism, NAD+ accepts electrons and hydrogen: NAD+ → NADH NADH can then donate those electrons during mitochondrial energy production. NAD+ is also consumed by signaling enzymes. This means cells must continually regenerate it. Humans can synthesize NAD+ through several pathways using precursors including: • Tryptophan • Nicotinamide • Nicotinic acid • Nicotinamide riboside • Nicotinamide mononucleotide
What Are Researchers Studying?
Cellular energy metabolism
NAD+/NADH is fundamental to: • Glycolysis • Pyruvate metabolism • The citric-acid cycle • Fatty-acid oxidation • Oxidative phosphorylation Rather than acting as a conventional stimulant, NAD+ participates directly in the biochemical reactions that allow cells to transfer energy. This role is so fundamental that NAD+ biology predates the modern longevity discussion by many decades.
Aging
NAD+ concentrations decline in multiple tissues during aging in many experimental models. Researchers have therefore investigated whether restoring NAD availability might influence age-associated dysfunction. Animal experiments involving NAD+ precursors have reported effects on: • Mitochondrial function • Metabolism • Muscle • DNA repair • Circadian biology • Neurobiology But the strongest intervention literature generally involves NAD+ precursors such as NR and NMN, rather than administration of NAD+ itself. That's an important evidence boundary for Aminodex.
Sirtuins
Sirtuins are NAD+-dependent enzymes involved in cellular regulation. They influence processes including: • Metabolism • Stress responses • Mitochondrial biology • Gene expression • Circadian regulation Because sirtuins consume NAD+, their activity is connected to cellular NAD availability. This relationship helped fuel the modern idea that manipulating NAD metabolism might influence aspects of aging. But: Increasing NAD+ ≠ automatically activating every beneficial sirtuin pathway. The system is much more complicated.
DNA repair
PARP enzymes consume NAD+ while responding to DNA damage. This creates an interesting relationship: DNA damage → PARP activation → NAD+ consumption Under extreme cellular stress, excessive PARP activation can substantially deplete NAD+. Researchers therefore study NAD metabolism in: • Aging • Oxidative injury • Neurodegeneration • Ischemia • Inflammation
CD38 and age-related NAD decline
CD38 is a major NAD-consuming enzyme. Experimental research suggests that increased CD38 activity in aging tissues may contribute to declining NAD availability. This has led to research into: • CD38 inhibition • NAD conservation • Immunometabolism • Age-associated inflammation Again, that is mechanistic biology—not evidence that simply administering NAD+ reverses aging.
Mitochondrial function
Because NAD+/NADH participates directly in mitochondrial metabolism, disruptions in NAD homeostasis can alter cellular energy production. Researchers have studied NAD manipulation in models involving: • Mitochondrial dysfunction • Muscle aging • Metabolic disease • Neurological disease • Cardiovascular disease The field is scientifically substantial, but therapeutic translation remains incomplete.
Exercise and skeletal muscle
Exercise changes NAD metabolism and activates several NAD-dependent pathways. Researchers have investigated whether NAD precursors can influence: • Muscle mitochondrial function • Exercise adaptation • Metabolic flexibility • Age-related muscle decline Human trials involving NR and NMN now exist. Those studies should be classified under the specific precursor administered, rather than automatically assigned to NAD+.
How Does It Work?
There isn't one NAD+ receptor responsible for its effects. Instead, NAD+ participates in numerous biochemical systems. Redox reactions NAD+ ⇄ NADH allows transfer of electrons during metabolism. Sirtuins Consume NAD+ during protein deacetylation and related reactions. PARPs Consume NAD+ during ADP-ribosylation involved in DNA-damage responses. CD38 Consumes NAD+ while producing calcium-signaling metabolites. SARM1 NAD degradation by SARM1 plays a major role in axonal degeneration after neuronal injury. This makes NAD+ fundamentally different from most compounds on Aminodex. It isn't primarily a receptor agonist. It's part of the metabolic currency of the cell.
What Does the Research Show?
Human research
There is enormous human research concerning: • NAD metabolism • NAD biomarkers • Aging • Metabolic disease • NAD-consuming enzymes • Niacin • Nicotinamide • NR • NMN But direct evidence for exogenously administered NAD+ itself is much thinner than the popularity of “NAD therapy” might suggest. That distinction needs to be explicit. A study showing NR → increased blood NAD metabolites doesn't prove IV NAD+ → same pharmacology. And neither automatically establishes anti-aging benefit.
Animal research
Animal research is extensive. Manipulating NAD metabolism in rodents can influence: • Metabolic health • Mitochondrial function • Insulin sensitivity • Muscle function • Neurodegeneration • Circadian biology • Age-related physiology Much of the modern enthusiasm for NAD restoration originated here.
In-vitro research
The molecular evidence is enormous. NAD-dependent biochemical pathways are among the best-characterized metabolic systems in biology. Research encompasses: • Redox chemistry • Mitochondrial metabolism • Sirtuins • PARPs • CD38 • DNA repair • Axonal degeneration • Metabolic signaling The uncertainty isn't whether NAD+ matters. It clearly does. The uncertainty is whether a particular external intervention produces a meaningful clinical benefit.
Notable Studies
Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication During Aging
animalResearchers demonstrated an age-associated decline in NAD+ and identified a mechanism linking NAD loss with impaired communication between nuclear and mitochondrial systems. Restoring NAD-related metabolism reversed several molecular abnormalities in aged mice.
Limitations: Mouse and cellular findings do not establish that NAD+ administration reverses human aging. The source labels this as preclinical — cellular + mouse aging research. The closest dropdown is Animal.
View publication →CD38 Ecto-Enzyme in Immune Cells Is Induced During Aging and Regulates NAD+ and NMN Levels
animalResearchers demonstrated that age-associated increases in CD38 contribute to declining NAD concentrations and interfere with NAD-precursor metabolism in mice.
Limitations: Establishing one mechanism of NAD decline does not establish clinical efficacy of NAD supplementation. The source labels this as preclinical — aging/metabolic mechanism. The closest dropdown is Animal.
View publication →What We Still Don't Know
• Clinical benefits of directly administered NAD+ • Oral bioavailability of intact NAD+ • Pharmacokinetics of different administration routes • Whether extracellular NAD+ reaches tissues intact • How much administered NAD+ is degraded before cellular uptake • Long-term safety of repeated high-dose administration • Whether NAD+ administration meaningfully affects aging • Whether it improves cognition • Whether it improves athletic performance • Whether it improves chronic fatigue • Whether it treats substance dependence • Whether increasing NAD availability is beneficial in every tissue • Whether chronic manipulation produces unwanted effects
Related Compounds
Recent publications
Latest titles from PubMed, not reviewed by Aminodex. Not an endorsement. See all on PubMed ↗
Take the Nicotinamide Adenine Dinucleotide research with you.
Get the Aminodex Nicotinamide Adenine Dinucleotide Brief—a concise summary of the research, notable studies, evidence types, limitations, and references.
One-time email. We do not add you to any mailing list.
Sources & References
- Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication During Aging. Gomes AP, Price NL, Ling AJY, et al. (2013). PubMed — NAD aging research. Link: https://pubmed.ncbi.nlm.nih.gov/24360282/
- CD38 Ecto-Enzyme in Immune Cells Is Induced During Aging and Regulates NAD+ and NMN Levels. Chini CCS, Peclat TR, Warner GM, et al. (2020). Nature Metabolism.
Supplier Listings
Disclosure: The owner of Aminodex operates the supplier(s) marked below. These listings are promotion for businesses we own, not independent recommendations. Read our disclosures.